Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam
- PMID: 17284293
- DOI: 10.1111/j.1528-1167.2006.00973.x
Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam
Abstract
Purpose: The present study explores the hypothesis that the antiepileptic mechanism of action of levetiracetam (LEV) is related to effects on alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor channels in mouse cortical neurons in culture.
Methods: The neurons were subjected to the whole-cell configuration of the patch-clamp recording technique and were 8-12 days old in culture.
Results: Kainate elicited concentration-dependent (EC(50)= 80 microM) inward currents in all the patched cells. LEV (5-200 microM) itself did not induce inward or outward currents on all patched neurons, whereas it was effective on the kainate- and AMPA-induced current because it significantly decreased the amplitude of these currents. LEV was also able to significantly decrease the total membrane conductance during kainate perfusion, indicating that its effect was not dependent on the cellular voltage membrane potential. Further evidence that LEV modulated the ionotropic non-NMDA receptors came from the analysis of miniature excitatory postsynaptic currents (mEPSCs). In fact, LEV significantly decreased both the amplitude and the frequency of mEPSCs, as shown by the relative cumulative distributions.
Conclusions: These results reveal that AMPA receptors are modulated by LEV because a significant decrease in the kainate- and AMPA-induced currents and a decrease in amplitude and in frequency of mEPSCs have been observed in cortical neurons in culture. The described effect of LEV on AMPA receptors in cortical neurons is probably due to the etheromeric composition of the receptors and may be considered as a possible new antiepileptic mechanism of action.
Similar articles
-
Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole.J Neurosci Res. 2004 Oct 15;78(2):200-7. doi: 10.1002/jnr.20244. J Neurosci Res. 2004. PMID: 15378511
-
Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis.Neurobiol Dis. 2011 Oct;44(1):92-101. doi: 10.1016/j.nbd.2011.06.008. Epub 2011 Jun 25. Neurobiol Dis. 2011. PMID: 21726643
-
Functional similarities and differences of AMPA and kainate receptors expressed by cultured rat sensory neurons.Neuroscience. 2004;129(1):35-48. doi: 10.1016/j.neuroscience.2004.07.015. Neuroscience. 2004. PMID: 15489026
-
Neuropharmacology of AMPA and kainate receptors.Neuropharmacology. 1998 Oct-Nov;37(10-11):1187-204. doi: 10.1016/s0028-3908(98)00139-7. Neuropharmacology. 1998. PMID: 9849657 Review. No abstract available.
-
[Levetiracetam: a molecule with a novel mechanism of action in the pharmaceutical treatment of epilepsy].Ideggyogy Sz. 2002 May 20;55(5-6):195-6. Ideggyogy Sz. 2002. PMID: 12122879 Review. Hungarian. No abstract available.
Cited by
-
Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain.Cells. 2022 Dec 13;11(24):4027. doi: 10.3390/cells11244027. Cells. 2022. PMID: 36552791 Free PMC article.
-
Changes in the Dentate Gyrus Gene Expression Profile Induced by Levetiracetam Treatment in Rats with Mesial Temporal Lobe Epilepsy.Int J Mol Sci. 2024 Jan 30;25(3):1690. doi: 10.3390/ijms25031690. Int J Mol Sci. 2024. PMID: 38338984 Free PMC article.
-
Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.Br J Pharmacol. 2009 Dec;158(7):1753-62. doi: 10.1111/j.1476-5381.2009.00463.x. Br J Pharmacol. 2009. PMID: 19888964 Free PMC article.
-
Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets.Front Pharmacol. 2022 Oct 14;13:948412. doi: 10.3389/fphar.2022.948412. eCollection 2022. Front Pharmacol. 2022. PMID: 36313347 Free PMC article. Review.
-
Screening for Activity Against AMPA Receptors Among Anticonvulsants-Focus on Phenytoin.Front Pharmacol. 2021 Dec 7;12:775040. doi: 10.3389/fphar.2021.775040. eCollection 2021. Front Pharmacol. 2021. PMID: 34950035 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources